Article Versions Notes

Zahn G, Willmes DM, El-Agroudy NN, Yarnold C, Jarjes-Pike R, Schaertl S, Schreiter K, Gehrmann W, Wong AKC, Zordan T, et al. A Novel and Cross-Species Active Mammalian INDY (NaCT) Inhibitor Ameliorates Hepatic Steatosis in Mice with Diet-Induced Obesity. Metabolites. 2022; 12(8):732. https://doi.org/10.3390/metabo12080732

Zahn, Grit, Diana M. Willmes, Nermeen N. El-Agroudy, Christopher Yarnold, Richard Jarjes-Pike, Sabine Schaertl, Kay Schreiter, Wiebke Gehrmann, Andrea Kuan Cie Wong, Tommaso Zordan, and et al. 2022. "A Novel and Cross-Species Active Mammalian INDY (NaCT) Inhibitor Ameliorates Hepatic Steatosis in Mice with Diet-Induced Obesity" Metabolites 12, no. 8: 732. https://doi.org/10.3390/metabo12080732

Zahn, G., Willmes, D. M., El-Agroudy, N. N., Yarnold, C., Jarjes-Pike, R., Schaertl, S., Schreiter, K., Gehrmann, W., Wong, A. K. C., Zordan, T., König, J., Jordan, J., & Birkenfeld, A. L. (2022). A Novel and Cross-Species Active Mammalian INDY (NaCT) Inhibitor Ameliorates Hepatic Steatosis in Mice with Diet-Induced Obesity. Metabolites, 12(8), 732. https://doi.org/10.3390/metabo12080732